Title |
The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis
|
---|---|
Published in |
BMC Infectious Diseases, October 2013
|
DOI | 10.1186/1471-2334-13-473 |
Pubmed ID | |
Authors |
Paola Scognamiglio, Giacomina Chiaradia, Gabriella De Carli, Massimo Giuliani, Claudio Maria Mastroianni, Stefano Aviani Barbacci, Anna Rita Buonomini, Susanna Grisetti, Alessandro Sampaolesi, Angela Corpolongo, Nicoletta Orchi, Vincenzo Puro, Giuseppe Ippolito, Enrico Girardi, for the SENDIH Study Group |
Abstract |
The aim of our work was to evaluate the potential impact of the European policy of testing for HIV all individuals presenting with an indicator disease, to prevent late diagnosis of HIV. We report on a retrospective analysis among individuals diagnosed with HIV to assess whether a history of certain diseases prior to HIV diagnosis was associated with the chance of presenting late for care, and to estimate the proportion of individuals presenting late who could have been diagnosed earlier if tested when the indicator disease was diagnosed. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Canada | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 82 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 18% |
Researcher | 14 | 16% |
Student > Bachelor | 11 | 13% |
Other | 8 | 9% |
Student > Doctoral Student | 4 | 5% |
Other | 8 | 9% |
Unknown | 25 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 36% |
Nursing and Health Professions | 5 | 6% |
Agricultural and Biological Sciences | 5 | 6% |
Social Sciences | 5 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 8 | 9% |
Unknown | 29 | 34% |